Table 4.
Association analysis between BGLAP HindIII and T2DM development.
| Model | P c | ORc (95% CI) | P a | ORa (95% CI) | P a b |
|---|---|---|---|---|---|
| Dominant | 0.155 | 0.746 (0.498-1.117) | 0.169 | 0.745 (0.489-1.134) | 0.676 |
| Recessive | 0.254 | 1.569 (0.723-3.406) | 0.134 | 1.861 (0.826-4.191) | 0.536 |
| Overdominant | 0.04 | 0.638 (0.415-0.979) | 0.03 | 0.608 (0.389-0.952) | 0.12 |
| Additivea | 0.058 | 0.656 (0.425-1.015) | 0.05 | 0.635 (0.403-1.0) | 0.2 |
| 0.437 | 1.366 (0.622-3.001) | 0.26 | 1.606 (0.704-3.663) | 1 |
P c: crude P value; ORc: crude odds ratio; Pa: P value after adjustment for age, sex, BMI, smoking, and arterial hypertension presence; ORa: adjusted odds ratio; Pab: P value after Bonferroni correction. aUpper row describes the comparison between CT and TT genotypes and lower row between CC and TT genotypes.